# Ganirelix

## Orgalutran inj 0.25mg/0.5mL

| TAH Drug Code      | [IORG](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IORG)                                                                                                                                                                                                   |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | For the inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation.                                                                                                                                                                     |
| Dosing             | 250 mcg once daily during the mid-to-late phase after initiating follicle-stimulating hormone on day 2 or 3 of cycle. Treatment should be continued daily until the day of chorionic gonadotropin administration.                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                          |
| Contraindications  | No Data                                                                                                                                                                                                                                                                |
| Adverse Effects    | Common Neurologic: Headache (3% ) Reproductive: Abdominal pain, Gynecological (4.8% ), Vaginal bleeding (1.8% ) Serious Immunologic: Hypersensitivity reaction Reproductive: Ovarian hyperstimulation syndrome (2.4% ) Other: Undelivered in utero fetal death (3.7% ) |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                |
| Lactation          | Unknown                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/ganirelix-drug-information)                                                                                                                                                                                               |

